Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

被引：0
作者：
Theodoros Karampitsakos
Apostolos Galaris
Serafeim Chrysikos
Ourania Papaioannou
Ioannis Vamvakaris
Ilianna Barbayianni
Paraskevi Kanellopoulou
Sofia Grammenoudi
Nektarios Anagnostopoulos
Grigoris Stratakos
Matthaios Katsaras
Fotios Sampsonas
Katerina Dimakou
Effrosyni D. Manali
Spyridon Papiris
Bochra Tourki
Brenda M Juan-Guardela
Petros Bakakos
Demosthenes Bouros
Jose D Herazo-Maya
Vassilis Aidinis
Argyris Tzouvelekis
机构：
[1] University Hospital of Patras,Department of Respiratory Medicine
[2] University of South Florida,Ubben Center and Laboratory for Pulmonary Fibrosis Research, Morsani College of Medicine
[3] Institute of Bio- Innovation,5th Department of Pneumonology
[4] Biomedical Sciences Research Center Alexander Fleming,Department of Pathology
[5] Hospital for Thoracic Diseases,First Academic Department of Pneumonology, “SOTIRIA”, Medical School
[6] “SOTIRIA”,2nd Pulmonary Medicine Department, Athens Medical School
[7] Hospital for Thoracic Diseases,undefined
[8] “SOTIRIA”,undefined
[9] Hospital for Thoracic Diseases,undefined
[10] National and Kapodistrian University of Athens,undefined
[11] “ATTIKON” University Hospital,undefined
[12] National and Kapodistrian University of Athens,undefined
来源：
Respiratory Research | / 24卷
关键词：
Idiopathic pulmonary fibrosis; Mediastinal lymph nodes; Lung cancer; PD-1/PD-L1 axis; Pembrolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection
    Scilla, Katherine A.
    Zandberg, Dan P.
    Bentzen, Soren M.
    Mainor, Candace
    Heath, Jonathon
    Ioffe, Olga B.
    Cellini, Ashley L.
    Edelman, Martin J.
    Riedel, David J.
    Feliciano, Josephine L.
    LUNG CANCER, 2018, 123 : 87 - 90
  • [42] FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation
    Madhi, Hamadi
    Lee, Jeon-Soo
    Choi, Young Eun
    Li, Yan
    Kim, Myoung Hee
    Choi, Yongdoo
    Goh, Sung-Ho
    ADVANCED SCIENCE, 2022, 9 (29)
  • [43] Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
    Munari, Enrico
    Marconi, Marcella
    Querzoli, Giulia
    Lunardi, Gianluigi
    Bertoglio, Pietro
    Ciompi, Francesco
    Tosadori, Alice
    Eccher, Albino
    Tumino, Nicola
    Quatrini, Linda
    Vacca, Paola
    Rossi, Giulio
    Cavazza, Alberto
    Martignoni, Guido
    Brunelli, Matteo
    Netto, George J.
    Moretta, Lorenzo
    Zamboni, Giuseppe
    Bogina, Giuseppe
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression
    Hu, Weilei
    Wang, Guosheng
    Yarmus, Lonny B.
    Wan, Yuan
    CANCERS, 2020, 12 (09) : 1 - 24
  • [45] RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis
    KL Watts
    E Cottrell
    PR Hoban
    MA Spiteri
    Respiratory Research, 7
  • [46] Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Gainor, J. F.
    Rizvi, H.
    Aguilar, E. Jimenez
    Skoulidis, F.
    Yeap, B. Y.
    Naidoo, J.
    Khosrowjerdi, S.
    Mooradian, M.
    Lydon, C.
    Illei, P.
    Zhang, J.
    Peterson, R.
    Ricciuti, B.
    Nishino, M.
    Roth, J. A.
    Grishman, J.
    Anderson, D.
    Little, B. P.
    Carter, B. W.
    Arbour, K.
    Sauter, J. L.
    Mino-Kenudson, M.
    Heymach, J., V
    Digumarthy, S.
    Shaw, A. T.
    Awad, M. M.
    Hellmann, M. D.
    ANNALS OF ONCOLOGY, 2020, 31 (03) : 404 - 411
  • [47] Immunosuppressive properties of human PD-1 + , PDL-1 + and CD80 + dendritic cells from lymph nodes aspirates of lung cancer patients
    Iwona Kwiecień
    Elżbieta Rutkowska
    Agata Raniszewska
    Rafał Sokołowski
    Joanna Bednarek
    Karina Jahnz-Różyk
    Piotr Rzepecki
    Joanna Domagała-Kulawik
    Cancer Immunology, Immunotherapy, 2022, 71 : 2469 - 2483
  • [48] Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients
    Shimoda, Yukiko
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Mizuno, Takaaki
    Jo, Hitomi
    Matsumoto, Yuji
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Yatabe, Yasushi
    Ohe, Yuichiro
    Motoi, Noriko
    ANTICANCER RESEARCH, 2021, 41 (11) : 5739 - 5747
  • [49] High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
    O, Y.
    Hishima, Tsunekazu
    Kashi, Jumpei
    Homma, Sadamu
    CANCER SCIENCE, 2018, 109 : 1099 - 1099
  • [50] PD-L1 expression in non-small cell lung cancer: heterogeneity by pathologic types, tissue sampling and metastasis
    Shen, Xuxia
    Wang, Yue
    Jin, Yan
    Zheng, Qiang
    Shen, Lei
    Chen, Ying
    Li, Yuan
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 4360 - +
12345